Index of artpub/2019/236894/

Orlowski, R.Z
Carfilzomib-Dexamethasone Versus Bortezomib-Dexamethasone in Relapsed or Refractory Multiple Myeloma : Updated Overall Survival, Safety, and Subgroups
2019
https://ddd.uab.cat/record/236894